Navigation Links
Global Health Progress Joins WHO and DNDi to Call For Increased Commitments to Fighting Neglected Tropical Diseases
Date:7/8/2008

One billion people suffer from preventable, treatable diseases around the world

Statement by Dr. Paul Antony, medical director Global Health Progress

TOYAKO, Japan, July 8 /PRNewswire-USNewswire/ -- "The worldwide pharmaceutical industry is joining the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi) in calling on the G-8 to recognize the importance of neglected diseases as a global health threat and a major strain on the economic viability and educational development of communities worldwide. We urge the G-8 to finance successful treatment and prevention programs, to support innovative strategies that address the challenging health gaps in developing countries, and to fund research and development to develop improved diagnostic, treatment and prevention options.

"Most international attention is focused on HIV/AIDS, tuberculosis, malaria and global health security. However, neglected tropical diseases - most of which are preventable and treatable - remain major causes of death and disability worldwide. These diseases receive less funding and less attention while they decrease productivity, negatively affect quality of life and increase poverty throughout the developing world.

"Partnerships supported by the research-based biopharmaceutical companies have provided billions of dollars in medicines, research and development, supplies, distribution networks and other resources to fight neglected diseases such as river blindness, trachoma, and lymphatic filariasis around the world. In the process, we have lowered the cost for effective treatments and made them available to hundreds of millions of people each year. Companies have also made substantial contributions to building health care capacity in developing countries, and are looking to implement more programs to address remaining gaps in care.

"However, the continuing threat of these diseases, which affect one in six people worldwide, and the lack of access to existing treatment and preventative measures makes it clear that there is more work to do. Involvement by the global community, particularly the countries of the G-8, is necessary to further efforts aimed at meeting the critical health challenges of the developing world."

Further information about efforts by research-based biopharmaceutical companies, please visit http://www.globalhealthprogress.org. For information about neglected tropical diseases, visit WHO at http://www.who.int/neglected_diseases/en/index.html or DNDi at http://www.dndi.org.

About Global Health Progress

The Global Health Progress initiative brings research-based biopharmaceutical companies and global health leaders together to improve health in the developing world. Through meaningful public-private partnerships with others in the field, including policymakers in the developed and developing world, multi-lateral institutions, non-governmental organizations, and academe, we are helping to shape sustainable solutions that improve the health of all people. For more information, please visit http://www.globalhealthprogress.org.


'/>"/>
SOURCE Global Health Progress
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Global Med Technologies(R) Announces U.S. Release of Proven Tissue and Cellular Therapy Product
2. Proposing a New Global Compact for Infectious Diseases
3. The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track
4. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
5. Signalife and Heart One Global Research Agree to Merge
6. AEGON and Right To Play Announce Global Partnership
7. MED3OOO and Mitsui & Co. Complete U.S. and Global Healthcare Partnership Agreement
8. National Press Club to Host NEWSMAKER Media Briefing on Global Health and the Infections of Poverty - Neglected Tropical Diseases
9. Chronic Kidney Disease Growing Globally
10. TechTeam Global Announces Formation of a Global Pharmaceutical Center of Excellence
11. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
Breaking Medicine Technology: